BofA Securities Downgrades LianBio (LIAN) to Underperform, 'lower pipeline optionality / quiet 2024'

January 3, 2024 6:07 AM EST Send to a Friend
(Updated - January 3, 2024 7:40 AM EST)

BofA Securities analyst Geoff Meacham downgraded LianBio (NASDAQ: LIAN) from Buy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login